The document “Appendix 3Y Change of Director’s Interest Notice” was lodged with ASX on 22 November, 2021.
Please click to review the full announcement at ASX.
Home » Appendix 3Y Change of Director’s Interest Notice
The document “Appendix 3Y Change of Director’s Interest Notice” was lodged with ASX on 22 November, 2021.
Please click to review the full announcement at ASX.
Bringing molecular specificity to MRI could change the way cancer is diagnosed. We’re proud of the first-of-its-kind technology behind MagSense®, but breakthrough technology alone does
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the
Separating lethal disease from indolent disease remains the persistent difficulty, and molecular MRI may offer a way to see the difference. Prostate cancer is the
We’re on a mission to make cancer more detectable.
